Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: Still controversial

被引：2

作者：

Beaulac-Baillargeon, Louise ^{[1
]}

Boucher, Nina ^{[1
]}

机构：

[1] Univ Laval, Fac Pharm, Ste Foy, PQ G1K 7P4, Canada

来源：

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE | 2006年 / 160卷 / 08期

关键词：

D O I：

10.1001/archpedi.160.8.855-b

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：855 / 856

页数：5

共 5 条

[1] The serotonin syndrome scale: first results on validity [J].

Hegerl, U ;

Bottlender, R ;

Gallinat, J ;

Kuss, HJ ;

Ackenheil, M ;

Moller, HJ .

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1998, 248 (02) :96-103

[2] A new indication for therapeutic drug monitoring in the neonate [J].

Koren, G .

THERAPEUTIC DRUG MONITORING, 2006, 28 (01) :1-1

[3] Neonatal abstinence syndrome after in utero exposure to selective serotonin Reuptake inhibitors in term infants [J].

Levison-Castiel, R ;

Merlob, P ;

Linder, N ;

Sirota, L ;

Klinger, G .

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (02) :173-176

[4] Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy - Effects on the infant [J].

Nordeng, H ;

Spigset, O .

DRUG SAFETY, 2005, 28 (07) :565-581

[5] A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate [J].

Rampono, J ;

Proud, S ;

Hackett, LP ;

Kristensen, JH ;

Ilett, KF .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (03) :329-334

← 1 →